SOD2 and Alzheimer disease: Second, this is a cross-sectional study; therefore, the biomarkers were only detected once, and further, large-scale longitudinal studies need to be conducted to demonstrate the dynamics of SOD2, DNase, MMP-2, and MMP-9 alterations along the spectrum of AD and their correlation with clinical and biological markers.